ERBB2 and breast carcinoma: The epidermal growth factor receptors HER1 (also denoted EGFR), HER2, HER3, and HER4 are involved in the pathogenesis and progression of solid tumors such as cancer of the breast, lung, bladder, colon, ovary, and stomach [1–3].